Related Experiment Video

Updated: Jun 30, 2026

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
08:13

Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

Published on: January 20, 2019

MeNZB vaccine and epidemic control: when do you stop vaccinating?

Belinda J Loring1, Nikki Turner, Helen Petousis-Harris

  • 1Toi Te Ora - Public Health, Bay of Plenty District Health Board, Tauranga, New Zealand. bjloring@yahoo.com

Vaccine
|September 23, 2008
PubMed

Insights

New Zealand

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • New Zealand implemented a targeted vaccination program using a strain-specific group B meningococcal vaccine to combat a rising epidemic.
  • The vaccination strategy involved an initial mass campaign for individuals under 20, followed by a routine four-dose schedule for infants from six weeks of age.

Purpose of the Study:

  • To discuss the multifaceted considerations involved in discontinuing an epidemic control vaccination program.
  • To provide insights into the decision-making process for ceasing meningococcal B vaccination campaigns, given limited international precedents.

Main Methods:

  • The study reviews epidemiological data, vaccine effectiveness, duration of immunity, and coverage rates.
  • It also considers the integration of the vaccine with other infant immunizations, supply chain logistics, and cost-benefit analyses.
  • Communication strategies for healthcare professionals and the public are also examined.

Main Results:

  • The decision to cease the group B meningococcal vaccination program required balancing various factors including disease burden, vaccine performance, and resource allocation.
  • Effective communication was identified as crucial for managing the transition among stakeholders.

Conclusions:

  • Discontinuing a public health vaccination program necessitates a comprehensive evaluation of scientific, logistical, and economic factors.
  • Careful planning and clear communication are essential for a successful program transition and maintaining public trust in vaccination initiatives.

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Related Concept Videos

Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccinations01:51

Vaccinations

Overview
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...